Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FLIRT: Rituximab IV vs SC in Low Tumor Burden Follicular Lymphoma
NCT02303119Phase 3Completed
- Sponsor
- LYSARC
- Start
- Feb 2015
- Primary completion
- Jun 2021
- Countries
- 1
01
Overview
A Phase 3 trial of rituximab in follicular lymphoma (FL), sponsored by LYSARC. Started Feb 2015; status: completed.
02
Drugs
rituximab
03
Conditions
follicular lymphoma (FL)
Beyond the preview
Go deeper on NCT02303119.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02303119.